A Digital Health Program for Non-Communicable Disease Prevention in a Workplace Setting in Thailand

NCT06265662 | Not Yet Recruiting

• 1 other identifier: 66701100301
• Study Type: interventional
• Target: 150
• Locations: 0 countries
• Sites: N/A

Brief Summary

The goal of this quasi-experimental study is to test the effectiveness of a digital health program designed to prevent non-communicable diseases (NCDs) in employees within a workplace setting in Thailand. The main questions it aims to answer are:

• Can a digital health program help participants lose weight?
• Does the digital health program improve other health outcomes such as Body Mass Index (BMI), blood lipid levels (triglycerides and LDL), blood sugar levels (HbA1c or fasting plasma glucose), and blood pressure? Is the digital health program feasible and acceptable in the Thai workplace setting, as measured by participation rates, usage, and participant satisfaction? Participants will:
• Attend four group health education sessions, each lasting one hour, scheduled over a six-month period.
• Have unlimited access to individual chat consultations with a healthcare team, including doctors, dietitians, fitness coaches, and psychologists, available from 9:00 AM to 5:00 PM on workdays, excluding public holidays.

Conditions

Chronic Disease; Noncommunicable Diseases

Keywords

Mobile Health; Self Care; Workplace; Health Promotion; Digital Medicine

Outcome Measures

Primary Outcomes (1)

• Weight

  To assess weight reduction.

  6 months

Secondary Outcomes (10)

• BMI

  6 months

• Total cholesterol

  6 months

• Triglycerides

  6 months

• HDL

  6 months

• LDL

  6 months

Study Arms (1)

The Intervention Arm

EXPERIMENTAL

Participants will engage in various activities, including: * Attending four group health education sessions, each lasting one hour, over a six-month period. * Having access to individual chat consultations with a healthcare team, including doctors, dietitians, fitness coaches, and psychologists, available from 9:00 AM to 5:00 PM on workdays, excluding public holidays, with no limit on consultation times.

Behavioral: A Digital Health Program for Non-Communicable Disease Prevention in a Workplace Setting in Thailand

Interventions

A Digital Health Program for Non-Communicable Disease Prevention in a Workplace Setting in Thailand BEHAVIORAL

The program consists of two main components: (1) Participants are invited to join health courses and/or health activities in the form of seminars or group activities, and (2) Participants will have access to an application that is part of the program, where they can consult with health experts to plan lifestyle modifications and reduce behavioral risk factors over the 6-month duration of the research project, totaling four sessions, each lasting one hour.

The Intervention Arm

Eligibility Criteria

• Age: 20 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Must have a Body Mass Index (BMI) indicating overweight, specifically between 23.0 and 27.5 kg/m². OR
• Must have blood lipid levels indicating risk, such as triglyceride levels between 150 and 199 mg/dL or LDL levels between 160 and 189 mg/dL. OR
• Must have blood sugar levels indicating a pre-diabetic state, such as an HbA1c level between 5.7% and 6.4% or fasting plasma glucose levels between 100 and 125 mg/dL. OR
• Must have systolic blood pressure between 120 and 139 mmHg and/or diastolic blood pressure between 80 and 89 mmHg.
• Must be able to read and communicate in Thai to participate in project activities.
• Must have access to digital devices compatible with the digital health program, such as smartphones with operating systems equivalent to or higher than iOS 11 or Android 5.1, or computers capable of joining online seminars.
• Must consent to participate in the research study.

You may not qualify if:

• Pregnancy, bedridden state, or disability that limits mobility or the ability to exercise.
• History of non-communicable diseases, such as heart disease, stroke, diabetes, or any acute illness.
• Participation in a health program or weight loss program currently or in the previous month.

Sponsors & Collaborators

• Chulalongkorn University: lead

Related Publications (30)

• กลุ่มเทคโนโลยี ระบาดวิทยา และมาตรการชุมชน กองโรคไม่ติดต่อ กรมควบคุมโรค กระทรวงสาธารณสุข. รายงานสถานการณ์โรค NCDs เบาหวาน ความดันโลหิตสูง และปัจจัยเสี่ยงที่เกี่ยวข้อง. 2020.

  BACKGROUND

• คณะกรรมการเศรษฐกิจและสังคมแห่งเอเชียและแปซิฟิก. เหตุผลสนับสนุนการลงทุนใน มาตรการป้องกันและควบคุมโรคไม่ติดต่อในประเทศไทย. 2021.

  BACKGROUND

• มูลนิธิสถาบันวิจัยและพัฒนาผู้สูงอายุไทย. สถานการณ์ผู้สูงอายุไทย พ.ศ. 2564. 2021.

  BACKGROUND

• World Health Organization. Noncommunicable diseases. Fact sheets 2023 16 September 2023 [cited 2023 16 November 2023]; Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.

  BACKGROUND

• Burton, J. WHO healthy workplace framework and model: background and supporting literature and practices. 2010: Geneva.

  BACKGROUND

• World Health Organization. World mental health report: transforming mental health for all. 2022: Geneva.

  BACKGROUND

• World Health Organization. The impact of the COVID-19 pandemic on noncommunicable disease resources and services: results of a rapid assessment. 2020.

  BACKGROUND

• วารณี บุญช่วยเหลือ, ทิพาพร พงษ์เมษา, และ กมลภัทร ไชยกิตติโสภน. การดําเนินงานลดเสี่ยงต่อโรคหัวใจและหลอดเลือดในกลุ่มวัยทํางาน ที่มีความคุ้มค่าหรือมีประสิทธิผล ในชุมชน สถานบริการสุขภาพและสถานที่ทํางาน. 2018.

  BACKGROUND

• World Health Organization. Global Strategy on Diet, Physical Activity and Health. 2004, World Health Organization: Global Strategy on Diet, Physical Activity and Health.

  BACKGROUND

• World Health Organization. Preventing Non Communicable Diseases in the Workplace through Diet and Physical Activity. 2008, World Health Organization, Geneva: WHO/World Economic Forum Report of a Joint Event.

  BACKGROUND

• Proper KI, van Oostrom SH. The effectiveness of workplace health promotion interventions on physical and mental health outcomes - a systematic review of reviews. Scand J Work Environ Health. 2019 Nov 1;45(6):546-559. doi: 10.5271/sjweh.3833. Epub 2019 May 28.

  PMID: 31134284 BACKGROUND

• Hafez D, Fedewa A, Moran M, O'Brien M, Ackermann R, Kullgren JT. Workplace Interventions to Prevent Type 2 Diabetes Mellitus: a Narrative Review. Curr Diab Rep. 2017 Feb;17(2):9. doi: 10.1007/s11892-017-0840-0.

  PMID: 28150162 BACKGROUND

• Schwarz PEH, Timpel P, Harst L, Greaves CJ, Ali MK, Lambert J, Weber MB, Almedawar MM, Morawietz H. Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention: JACC Health Promotion Series. J Am Coll Cardiol. 2018 Oct 9;72(15):1829-1844. doi: 10.1016/j.jacc.2018.07.081.

  PMID: 30286928 BACKGROUND

• Cannon MJ, Ng BP, Lloyd K, Reynolds J, Ely EK. Delivering the National Diabetes Prevention Program: Assessment of Enrollment in In-Person and Virtual Organizations. J Diabetes Res. 2022 Feb 1;2022:2942918. doi: 10.1155/2022/2942918. eCollection 2022.

  PMID: 35118160 BACKGROUND

• Moungngern Y, S.S., Teparak P, Sriwijitkamol A. Effects of a Health Promotion Program Conducted by Nurses on Stabilization of HbA1C in Subjects at Risk for Diabetes: A Phase III Randomized Controlled Trial. J Med Assoc Thai, 2018. 101(10): p. 1343-8.

  BACKGROUND

• Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ, Khunti K. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014 Apr;37(4):922-33. doi: 10.2337/dc13-2195.

  PMID: 24652723 BACKGROUND

• Van Rhoon L, Byrne M, Morrissey E, Murphy J, McSharry J. A systematic review of the behaviour change techniques and digital features in technology-driven type 2 diabetes prevention interventions. Digit Health. 2020 Mar 24;6:2055207620914427. doi: 10.1177/2055207620914427. eCollection 2020 Jan-Dec.

  PMID: 32269830 BACKGROUND

• World Health Organization. Self-care interventions for health. Self-care interventions for health 2022 [cited 2023 19 November 2023]; Available from: https://www.who.int/news-room/fact-sheets/detail/self-care-health-interventions.

  BACKGROUND

• Skinner, D., S. Pete, and E.-O. Austen. Self-Care 2030: What does the future for health & wellbeing look like & how do we get there?, in School of Public Health. 2023.

  BACKGROUND

• Zhang CQ, Zhang R, Schwarzer R, Hagger MS. A meta-analysis of the health action process approach. Health Psychol. 2019 Jul;38(7):623-637. doi: 10.1037/hea0000728. Epub 2019 Apr 11.

  PMID: 30973747 BACKGROUND

• Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, Altman DG, Barbour V, Macdonald H, Johnston M, Lamb SE, Dixon-Woods M, McCulloch P, Wyatt JC, Chan AW, Michie S. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014 Mar 7;348:g1687. doi: 10.1136/bmj.g1687.

  PMID: 24609605 BACKGROUND

• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004 Jan 10;363(9403):157-63. doi: 10.1016/S0140-6736(03)15268-3.

  PMID: 14726171 BACKGROUND

• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486. No abstract available.

  PMID: 11368702 BACKGROUND

• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206-52. doi: 10.1161/01.HYP.0000107251.49515.c2. Epub 2003 Dec 1.

  PMID: 14656957 BACKGROUND

• Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002 Dec;25(12):2165-71. doi: 10.2337/diacare.25.12.2165.

  PMID: 12453955 BACKGROUND

• Schwarzer, R. Modeling Health Behavior Change: How to Predict and Modify the Adoption and Maintenance of Health Behaviors. Applied Psychology, 2008. 57(1): p. 1-29.

  BACKGROUND

• Schwarzer, R. Health action process approach (HAPA) as a theoretical framework to understand behavior change. Actualidades en Psicología, 2016. 30(121): p. 119-130.

  BACKGROUND

• Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6):393-403. doi: 10.1056/NEJMoa012512.

  PMID: 11832527 RESULT

• Katula JA, Dressler EV, Kittel CA, Harvin LN, Almeida FA, Wilson KE, Michaud TL, Porter GC, Brito FA, Goessl CL, Jasik CB, Sweet CMC, Schwab R, Estabrooks PA. Effects of a Digital Diabetes Prevention Program: An RCT. Am J Prev Med. 2022 Apr;62(4):567-577. doi: 10.1016/j.amepre.2021.10.023. Epub 2022 Feb 10.

  PMID: 35151522 RESULT

• Aekplakorn W, Tantayotai V, Numsangkul S, Tatsato N, Luckanajantachote P, Himathongkam T. Evaluation of a Community-Based Diabetes Prevention Program in Thailand: A Cluster Randomized Controlled Trial. J Prim Care Community Health. 2019 Jan-Dec;10:2150132719847374. doi: 10.1177/2150132719847374.

  PMID: 31079517 RESULT

MeSH Terms

Conditions

Chronic Disease; Noncommunicable Diseases

Interventions

Tacrine

Condition Hierarchy (Ancestors)

Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Aminoacridines; Acridines; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, Fused-Ring; Heterocyclic Compounds

Study Officials

• Jate Ratanachina, MD MSc PhD

  Chulalongkorn University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Zethapong Nimmanterdwong, MD

CONTACT

(+66)22527864; zethapong@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Student

Model Details: Single-arm quasi-experimental study for evaluating the effectiveness of a digital health program in weight reduction for the prevention of non-communicable diseases in the Thai workplace setting.

Study Record Dates

• First Submitted: February 12, 2024
• First Posted: February 20, 2024
• Study Start: June 1, 2024
• Primary Completion: September 1, 2025
• Study Completion: September 1, 2025
• Last Updated: May 31, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share